Select therapeutic use:

Anxiety/OCD:

Indications for BUTISOL SODIUM ORAL SOLUTION:

For use as a sedative or hypnotic.

Adult:

Use lowest effective dose. 15–30mg 3 or 4 times daily. Pre-op sedative: 50–100mg 60–90mins before surgery. Elderly, debilitated, hepatic or renal impairment: reduce dose.

Children:

Pre-op sedative: 2–6mg/kg, max 100mg.

Contraindications:

Manifest or latent porphyria.

Warnings/Precautions:

Premonitory signs of hepatic coma: not recommended. Renal or hepatic impairment. Acute or chronic pain. Depression. Suicidal tendencies. Drug or alcohol abuse. Monitor hematopoietic, renal, hepatic systems with long-term therapy. Avoid abrupt cessation. Write ℞ for smallest practical amount. Elderly (higher risk of falls). Debilitated. Labor & delivery. Pregnancy. Nursing mothers.

See Also:

Pharmacologic Class:

Barbiturate.

Interactions:

Avoid concomitant griseofulvin. May antagonize oral anticoagulants (eg, warfarin), corticosteroids (may require dosage adjustments), doxycycline (monitor), oral contraceptives (consider alternative contraceptive method). May be potentiated by sodium valproate, valproic acid, MAOIs. Additive CNS depressant effects with alcohol, other CNS depressants. Concomitant phenytoin: monitor blood levels frequently.

Adverse Reactions:

Somnolence, agitation, confusion, hyperkinesia, ataxia, CNS depression, nightmares, nervousness, psychiatric disturbance, complex behaviors (eg, sleep-driving), hallucination, insomnia, anxiety, dizziness, abnormal thinking, hypoventilation, apnea, bradycardia, hypotension, syncope, GI upset, constipation, headache, hypersensitivity reactions (eg, angioedema: do not rechallenge if occurs), fever, liver damage.

How Supplied:

Tabs—100; Oral soln—pint

Sleep-wake disorders:

Indications for BUTISOL SODIUM ORAL SOLUTION:

For use as a sedative or hypnotic.

Adult:

Use lowest effective dose. 50–100mg at bedtime. Limit use to 2 weeks. Elderly, debilitated, hepatic or renal impairment: reduce dose.

Children:

Not recommended.

Contraindications:

Manifest or latent porphyria.

Warnings/Precautions:

Premonitory signs of hepatic coma: not recommended. Renal or hepatic impairment. Acute or chronic pain. Depression. Suicidal tendencies. Drug or alcohol abuse. Monitor hematopoietic, renal, hepatic systems with long-term therapy. Avoid abrupt cessation. Write ℞ for smallest practical amount. Elderly (higher risk of falls). Debilitated. Labor & delivery. Pregnancy. Nursing mothers.

See Also:

Pharmacologic Class:

Barbiturate.

Interactions:

Avoid concomitant griseofulvin. May antagonize oral anticoagulants (eg, warfarin), corticosteroids (may require dosage adjustments), doxycycline (monitor), oral contraceptives (consider alternative contraceptive method). May be potentiated by sodium valproate, valproic acid, MAOIs. Additive CNS depressant effects with alcohol, other CNS depressants. Concomitant phenytoin: monitor blood levels frequently.

Adverse Reactions:

Somnolence, agitation, confusion, hyperkinesia, ataxia, CNS depression, nightmares, nervousness, psychiatric disturbance, complex behaviors (eg, sleep-driving), hallucination, insomnia, anxiety, dizziness, abnormal thinking, hypoventilation, apnea, bradycardia, hypotension, syncope, GI upset, constipation, headache, hypersensitivity reactions (eg, angioedema: do not rechallenge if occurs), fever, liver damage.

How Supplied:

Tabs—100; Oral soln—pint